Skip to search formSkip to main contentSkip to account menu

Arbaclofen

Known as: Baclofen R-, d-Baclofen, (R)-(-)-Baclofen 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2017
Highly Cited
2017
Several lines of emerging data point to an imbalance between neuronal excitation and inhibition in at least a subgroup of… 
Highly Cited
2017
Highly Cited
2017
Abstract Fragile X syndrome is a genetic condition resulting from FMR1 gene mutation that leads to intellectual disability… 
Highly Cited
2016
Highly Cited
2016
BackgroundArbaclofen improved multiple abnormal phenotypes in animal models of fragile X syndrome (FXS) and showed promising… 
Highly Cited
2014
Highly Cited
2014
STX209 (arbaclofen), a selective GABA-B agonist, is hypothesized to modulate the balance of excitatory to inhibitory… 
Review
2014
Review
2014
  • R. Frye
  • Drug, healthcare and patient safety
  • 2014
  • Corpus ID: 15287818
Autism spectrum disorder (ASD) is a behaviorally defined disorder which has increased in prevalence over the last two decades… 
Review
2013
Review
2013
RationaleAdvances in understanding the underlying mechanisms of conditions such as fragile X syndrome (FXS) and autism spectrum… 
Review
2013
Review
2013
  • C. Woolf
  • The Lancet Neurology
  • 2013
  • Corpus ID: 8697382
Highly Cited
2012
Highly Cited
2012
Administration of a selective GABAB agonist to individuals with fragile X syndrome improves their deficits in social avoidance, a… 
Highly Cited
2012
Highly Cited
2012
Pharmacological activation of the GABAB receptor with arbaclofen in a mouse model of fragile X syndrome corrects neuronal defects… 
2012
2012